Ganapati Mudur, “Pufferfish, Pigs and Silkworms: Asia Emerges as a Genomics Actor,” p. 40, is a science journalist in New Delhi, India. He has been writing about research as well as policy issues in science, technology, and medicine for 15 years, covering wide-ranging beats — from geosciences to public health to space technology. He was a Knight Science Journalism Fellow at MIT during 1999-2000, a time that he says he spent “gearing up for the century of the genome.”
Julia Karow, “Brookhaven Gets a Hand,” p. 30, was lured to the Big Apple by her husband. After finishing her PhD in biochemistry at Oxford University, she decided that talking to scientists might be more gratifying than talking to molecules (it turns out neither answers every question, she says). While earning an MA in science journalism at NYU, she interned at Scientific American, NPR’s Science Friday, and Süddeutsche Zeitung. She still tries to hide her German accent, to no avail. As GenomeWeb’s editorial intern, Julia has contributed to BioArray News, ProteoMonitor, and BioInform as well as this magazine.
Corrections
Amanda E. Baker, age 9, would like to note that David Baker (Wild Type, November 2001, p. 46) has a daughter and a son, not two sons.
Bryant Ng, account coordinator for Cepheid at Versaggi Biocommunications, writes: “In ‘Genomics on High Alert’ (November 2001, p. 32) it is mentioned that Cepheid and ETG have a contract with the DOD to deliver handheld devices. No contract currently exists between Cepheid/ETG and the DOD for the handheld devices. On the same page, it is mentioned that: ‘Cepheid has supplied PCR technology for the DOD’s BIDS vehicles...’ ETG does make the BIDS unit currently used by the DOD, which is based on immunoassay technology. ETG wants to upgrade that type of integrated system to Cepheid’s DNA testing technology, and that too is part of our agreement with ETG.”